Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2013-02-01
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
moderate
assessed
2026-08-18
Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-15 (study day 43.0); relationship: PROBABLE
mild
assessed
2026-08-18
Mild MALIGNANT FIBROUS HISTIOCYTOMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-19 (study day 19.0); relationship: NONE
mild
assessed
2026-08-18
Mild MALIGNANT FIBROUS HISTIOCYTOMA — outcome: RECOVERED/RESOLVED; onset 2013-02-19 (study day 19.0); relationship: NONE
moderate
assessed
2026-08-18
Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-15 (study day 43.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.